Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
C. Desbans, C. Hilgendorf, M. Lutz, P. Bachellier, T. Zacharias, J. C. Weber, H. Dolgos, L. Richert & A.-L. Ungell. (2014) Prediction of fraction metabolized via CYP3A in humans utilizing cryopreserved human hepatocytes from a set of 12 single donors. Xenobiotica 44:1, pages 17-27.
Read now
Read now
Eliane Alexandre, Audrey Baze, Céline Parmentier, Coraline Desbans, Dumrongsak Pekthong, Brigitte Gerin, Claudine Wack, Philippe Bachellier, Bruno Heyd, Jean-Christophe Weber & Lysiane Richert. (2012) Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers. Xenobiotica 42:10, pages 968-979.
Read now
Read now
A.-K. Sohlenius-Sternbeck, L. Afzelius, P. Prusis, J. Neelissen, J. Hoogstraate, J. Johansson, E. Floby, A. Bengtsson, O. Gissberg, J. Sternbeck & C. Petersson. (2010) Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds. Xenobiotica 40:9, pages 637-649.
Read now
Read now
R. Stringer, P. L. Nicklin & J. B. Houston. (2008) Reliability of human cryopreserved hepatocytes and liver microsomes as systems to predict metabolic clearance. Xenobiotica 38:10, pages 1313-1329.
Read now
Read now
G. I. Somers, M. K. Bayliss & J. B. Houston. (2007) The metabolism of the 5HT3 antagonists, ondansetron, alosetron and GR87442 II: Investigation into the in vitro methods used to predict the in vivo hepatic clearance of ondansetron, alosetron and GR87442 in the rat, dog and human. Xenobiotica 37:8, pages 855-869.
Read now
Read now
Nicola J. Hewitt, María José Gómez Lechón, J. Brian Houston, David Hallifax, Hayley S. Brown, Patrick Maurel, J. Gerald Kenna, Lena Gustavsson, Christina Lohmann, Christian Skonberg, Andre Guillouzo, Gregor Tuschl, Albert P. Li, Edward LeCluyse, Geny M. M. Groothuis & Jan G. Hengstler. (2007) Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies. Drug Metabolism Reviews 39:1, pages 159-234.
Read now
Read now
Articles from other publishers (34)
Sébastien Grégoire, Anne Moustié, Guillaume Lereaux, Laurène Roussel‐Berlier & Nicky Hewitt. (2024) Use of in vitro ADME methods to identify suitable analogs of homosalate and octisalate for use in a read‐across safety assessment. Journal of Applied Toxicology.
Crossref
Crossref
Wing Y. Tuet, Samuel A. Pierce, Matthieu Conroy, Justin N. Vignola, Justin Tressler, Robert C. diTargiani, Bryan J. McCranor & Benjamin Wong. (2022)
Metabolic clearance of select opioids and opioid antagonists using hepatic spheroids and recombinant cytochrome
P450
enzymes
. Pharmacology Research & Perspectives 10:5.
Crossref
Crossref
Tsubasa Kameyama, Jasleen K. Sodhi & Leslie Z. Benet. (2022) Does Addition of Protein to Hepatocyte or Microsomal In Vitro Incubations Provide a Useful Improvement in In Vitro-In Vivo Extrapolation Predictability?. Drug Metabolism and Disposition 50:4, pages 401-412.
Crossref
Crossref
L. J. Francis, J. B. Houston & D. Hallifax. (2021) Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation. Drug Metabolism and Disposition 49:3, pages 188-201.
Crossref
Crossref
Jung-Hwan Kwon, Hyun-Jeoung Lee & Beate I. Escher. (2020) Bioavailability of hydrophobic organic chemicals on an in vitro metabolic transformation using rat liver S9 fraction. Toxicology in Vitro 66, pages 104835.
Crossref
Crossref
Jochem Louisse, Martin Alewijn, Ad A.C.M. Peijnenburg, Nicole H.P. Cnubben, Minne B. Heringa, Sandra Coecke & Ans Punt. (2020) Towards harmonization of test methods for in vitro hepatic clearance studies. Toxicology in Vitro 63, pages 104722.
Crossref
Crossref
Christine M. Bowman & Leslie Z. Benet. (2019) Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties. Pharmaceutical Research 36:8.
Crossref
Crossref
Soo-Jin Kim, Kyeong-Ryoon Lee, Seiji Miyauchi & Yuichi Sugiyama. (2019) Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the “Albumin-Mediated” Hepatic Uptake Mechanism on the Basis of the “Facilitated-Dissociation Model”. Drug Metabolism and Disposition 47:2, pages 94-103.
Crossref
Crossref
Varvara Gouliarmou, Alfonso Maria Lostia, Sandra Coecke, Camilla Bernasconi, Jos Bessems, Jean Lou Dorne, Stephen Ferguson, Emanuela Testai, Ursula Gundert Remy, J. Brian Houston, Mario Monshouwer, Andy Nong, Olavi Pelkonen, Siegfried Morath, Barbara A. Wetmore, Andrew Worth, Ugo Zanelli, Maria Chiara Zorzoli & Maurice Whelan. (2018) Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance. Toxicology in Vitro 53, pages 233-244.
Crossref
Crossref
F. L. Wood, J. B. Houston & D. Hallifax. (2017) Clearance Prediction Methodology Needs Fundamental Improvement: Trends Common to Rat and Human Hepatocytes/Microsomes and Implications for Experimental Methodology. Drug Metabolism and Disposition 45:11, pages 1178-1188.
Crossref
Crossref
J. Matthew Hutzler, Barbara J. Ring & Shelby R. Anderson. (2015) Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists. Drug Metabolism and Disposition 43:12, pages 1917-1928.
Crossref
Crossref
Regis Baudoin, Audrey Legendre, Sebastien Jacques, Jerome Cotton, Frederic Bois & Eric Leclerc. (2014) Evaluation of a Liver Microfluidic Biochip to Predict In Vivo Clearances of Seven Drugs in Rats. Journal of Pharmaceutical Sciences 103:2, pages 706-718.
Crossref
Crossref
Céline Parmentier, Germaine L. Truisi, Konrad Moenks, Sven Stanzel, Arno Lukas, Annette Kopp-Schneider, Eliane Alexandre, Philip G. Hewitt, Stefan O. Mueller & Lysiane Richert. (2013) Transcriptomic Hepatotoxicity Signature of Chlorpromazine after Short- and Long-Term Exposure in Primary Human Sandwich Cultures. Drug Metabolism and Disposition 41:10, pages 1835-1842.
Crossref
Crossref
Patricio Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes Georg Bode, Jennifer Bolleyn, Christoph Borner, Jan Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, María Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Chris E. P. Goldring, María José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann-Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens M. Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak-Ublick, Edward L. LeCluyse, Peng Lu, Jennifer Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz-Soja, Patrick McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nussler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan A. Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiss, Agata Widera, Courtney G. Woods, Jinghai James Xu, Kathy M. Yarborough & Jan G. Hengstler. (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archives of Toxicology 87:8, pages 1315-1530.
Crossref
Crossref
Angela Dudda & Gert Ulrich Kuerzel. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1053
1094
.
Alexander V. LyubimovJasminder Sahi, Cornelia Smith, LaHoma Easterwood, Susan Grepper & Edward LeCluyse. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
53
.
Paulo Paixão, Luís F. Gouveia & José A.G. Morais. (2012) Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model. International Journal of Pharmaceutics 429:1-2, pages 84-98.
Crossref
Crossref
Jean Matthieu Prot & Eric Leclerc. (2011) The Current Status of Alternatives to Animal Testing and Predictive Toxicology Methods Using Liver Microfluidic Biochips. Annals of Biomedical Engineering 40:6, pages 1228-1243.
Crossref
Crossref
Patrick Poulin, Jane R. Kenny, Cornelis E.C.A. Hop & Sami Haddad. (2012) In Vitro–In Vivo Extrapolation of Clearance: Modeling Hepatic Metabolic Clearance of Highly Bound Drugs and Comparative Assessment with Existing Calculation Methods. Journal of Pharmaceutical Sciences 101:2, pages 838-851.
Crossref
Crossref
Tom De Bruyn, Zhi-Wei Ye, Annelies Peeters, Jasminder Sahi, Myriam Baes, Patrick F. Augustijns & Pieter P. Annaert. (2011) Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes. European Journal of Pharmaceutical Sciences 43:4, pages 297-307.
Crossref
Crossref
Paulo Paixão, Luís F. Gouveia & José A.G. Morais. (2010) Prediction of the in vitro intrinsic clearance determined in suspensions of human hepatocytes by using artificial neural networks. European Journal of Pharmaceutical Sciences 39:5, pages 310-321.
Crossref
Crossref
Urban Fagerholm. (2007) Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance. Journal of Pharmacy and Pharmacology 59:6, pages 803-828.
Crossref
Crossref
Nadège Blanchard, Nicola J Hewitt, Paul Silber, Hannah Jones, Philippe Coassolo & Thierry Lave. (2006) Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations. Journal of Pharmacy and Pharmacology 58:5, pages 633-641.
Crossref
Crossref
Sudhakar Garad, Jianling Wang, Yatindra Joshi & Riccardo Panicucci. 2010. Pharmaceutical Suspensions. Pharmaceutical Suspensions
127
176
.
Masato Chiba, Yasuyuki Ishii & Yuichi Sugiyama. (2009) Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development. The AAPS Journal 11:2.
Crossref
Crossref
Xing Han, Robert T. Mingoia, Diane L. Nabb, Ching-Hui Yang, Suzanne I. Snajdr & Robert A. Hoke. (2008) Xenobiotic intrinsic clearance in freshly isolated hepatocytes from rainbow trout (Oncorhynchus mykiss): Determination of trout hepatocellularity, optimization of cell concentrations and comparison of serum and serum-free incubations. Aquatic Toxicology 89:1, pages 11-17.
Crossref
Crossref
Albert P. Li. (2007) Human hepatocytes: Isolation, cryopreservation and applications in drug development. Chemico-Biological Interactions 168:1, pages 16-29.
Crossref
Crossref
Trudy Rodgers & Malcolm Rowland. (2007) Mechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes. Pharmaceutical Research 24:5, pages 918-933.
Crossref
Crossref
G. Elaut, G. Laus, E. Alexandre, L. Richert, P. Bachellier, D. Tourwé, V. Rogiers & T. Vanhaecke. (2007) A Metabolic Screening Study of Trichostatin A (TSA) and TSA-Like Histone Deacetylase Inhibitors in Rat and Human Primary Hepatocyte Cultures. Journal of Pharmacology and Experimental Therapeutics 321:1, pages 400-408.
Crossref
Crossref
Jiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan & Geoffrey T. Tucker. (2007) Misuse of the Well-Stirred Model of Hepatic Drug Clearance: Fig. 1.. Drug Metabolism and Disposition 35:3, pages 501-502.
Crossref
Crossref
Delphine Jouin, Nadège Blanchard, Eliane Alexandre, Frédéric Delobel, Pascale David-Pierson, Thierry Lavé, Daniel Jaeck, Lysiane Richert & Philippe Coassolo. (2006) Cryopreserved human hepatocytes in suspension are a convenient high throughput tool for the prediction of metabolic clearance. European Journal of Pharmaceutics and Biopharmaceutics 63:3, pages 347-355.
Crossref
Crossref
Giulia Ghibellini, Elaine M. Leslie & Kim L. R. Brouwer. (2006) Methods To Evaluate Biliary Excretion of Drugs in Humans: An Updated Review. Molecular Pharmaceutics 3:3, pages 198-211.
Crossref
Crossref
Lysiane Richert, Michael J. Liguori, Catherine Abadie, Bruno Heyd, Georges Mantion, Nermin Halkic & Jeffrey F. Waring. (2006) GENE EXPRESSION IN HUMAN HEPATOCYTES IN SUSPENSION AFTER ISOLATION IS SIMILAR TO THE LIVER OF ORIGIN, IS NOT AFFECTED BY HEPATOCYTE COLD STORAGE AND CRYOPRESERVATION, BUT IS STRONGLY CHANGED AFTER HEPATOCYTE PLATING. Drug Metabolism and Disposition 34:5, pages 870-879.
Crossref
Crossref
Robert J. Riley, D. F. McGinnity & R. P. Austin. (2005) A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES. Drug Metabolism and Disposition 33:9, pages 1304-1311.
Crossref
Crossref